Oppenheimer Asset Management Inc. Cuts Stock Holdings in Humana Inc. (NYSE:HUM)

Oppenheimer Asset Management Inc. cut its position in shares of Humana Inc. (NYSE:HUM) by 1.6% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 19,647 shares of the insurance provider’s stock after selling 310 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Humana were worth $6,223,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Creative Financial Designs Inc. ADV raised its position in shares of Humana by 244.0% in the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 61 shares during the period. CarsonAllaria Wealth Management Ltd. increased its stake in shares of Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after purchasing an additional 39 shares in the last quarter. Atwood & Palmer Inc. acquired a new position in Humana in the 3rd quarter worth about $29,000. Ashton Thomas Securities LLC purchased a new position in Humana during the third quarter worth approximately $31,000. Finally, Your Advocates Ltd. LLP grew its holdings in Humana by 81.8% in the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after purchasing an additional 45 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Ratings Changes

HUM has been the subject of several research analyst reports. TD Cowen upped their target price on Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research report on Thursday, October 3rd. Bank of America upgraded shares of Humana from an “underperform” rating to a “neutral” rating and lifted their target price for the company from $247.00 to $308.00 in a research report on Wednesday, November 6th. Oppenheimer reduced their price target on shares of Humana from $400.00 to $280.00 and set an “outperform” rating for the company in a research report on Thursday, October 3rd. Finally, UBS Group lowered their price objective on Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, October 4th. Twenty analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, Humana presently has a consensus rating of “Hold” and a consensus target price of $315.86.

Humana Price Performance

Humana stock opened at $282.97 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The company has a 50-day moving average price of $284.64 and a 200 day moving average price of $332.14. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $527.18. The stock has a market cap of $34.07 billion, a P/E ratio of 25.06, a PEG ratio of 2.21 and a beta of 0.52.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The business had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Sell-side analysts anticipate that Humana Inc. will post 15.83 earnings per share for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.25%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is presently 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.